Bain Capital sole contender for Vitabiotics buy

The group’s Indian arm, Meyer Vitabiotics, accounts for around 20% of the total Rs 3,000 crore (£253 million) in annual sales. Within Meyer’s portfolio, Calcimax holds a strong presence across paediatrics, diabetes, cardiac care, and women’s health segments, particularly in pregnancy and menopause.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/wo7O2pS
via gqrds

Comments

Popular posts from this blog

SC transfers PIL seeking implementation of law on mental health care to NHRC

Women in India Report Higher Sleep Deprivation Than Men

Over 9.19 crore hospital admissions facilitated under Ayushman Bharat since 2018